Urologic Neoplasms

Showing 1 - 25 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Clinical Significance of Adherent Perinephric Fat in Patients

Recruiting
  • Renal Cell Carcinoma
  • +4 more
    • Otwock, Poland
      European Health Centre, Second Department of Urology, Centre of
    May 31, 2023

    Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

    Active, not recruiting
    • Carcinoma
    • +7 more
    • La Jolla, California
    • +58 more
    Jan 13, 2023

    Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

    Active, not recruiting
    • Carcinoma, Transitional Cell
    • +6 more
    • enfortumab vedotin (EV)
    • +4 more
    • Anchorage, Alaska
    • +105 more
    Dec 19, 2022

    Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

    Recruiting
    • Uterine Neoplasms
    • +5 more
    • Goodyear, Arizona
    • +63 more
    Aug 15, 2022

    Bladder Tumor, Prostate Tumor, Pelvic Tumor Trial in Edmonton (Rectus sheath block, Bilateral rectus sheath catheter, Patient

    Completed
    • Bladder Neoplasm
    • +6 more
    • Rectus sheath block
    • +3 more
    • Edmonton, Alberta, Canada
      University of Alberta
    Jul 25, 2022

    Cancer, Urologic Tumors, Gynecologic Cancer Trial in Istanbul (INHA, TIVA)

    Withdrawn
    • Cancer
    • +2 more
    • INHA
    • TIVA
    • Istanbul, Bagcilar, Turkey
      Istanbul Medipol University Hospital
    Apr 28, 2022

    Abdominal Hernia, Abdominal Wall Defect, Abdominal Tumor Trial in La Louvière (VPC syringe)

    Recruiting
    • Abdominal Hernia
    • +6 more
    • VPC syringe
    • La Louvière, Hainaut, Belgium
      Chu Tivoli
    Apr 1, 2022

    Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

    Completed
    • Bladder Cancer Cell Transitional
    • +9 more
    • Tucson, Arizona
    • +4 more
    Jan 18, 2022

    Bladder Cancer, Urinary Bladder Tumor, Urologic Tumors Trial in Los Angeles, Boston (Fiducial marker placement, Multiparametric

    Recruiting
    • Bladder Cancer
    • +4 more
    • Fiducial marker placement
    • Multiparametric MRI (mpMRI)
    • Los Angeles, California
    • +1 more
    Jan 7, 2022

    Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce

    Completed
    • Bladder Cancer
    • +8 more
    • NanoDoce (direct injection)
    • +3 more
    • Phoenix, Arizona
    • +4 more
    Nov 29, 2021

    Metastatic Renal Cell Carcinoma, Kidney Cancer, Kidney Tumor Trial in Herlev (Electronic patient-reported outcomes regarding

    Not yet recruiting
    • Metastatic Renal Cell Carcinoma
    • +5 more
    • Electronic patient-reported outcomes regarding symptoms and health-related quality of life
    • Herlev, Denmark
      Department of Oncology, Herlev and Gentofte Hospital
    Nov 15, 2021

    Urologic Tumors Trial (Transvaginal natural orifice specimen extraction (NOSE), Transabdominal specimen extraction)

    Not yet recruiting
    • Urologic Neoplasms
    • Transvaginal natural orifice specimen extraction (NOSE)
    • Transabdominal specimen extraction
    • (no location specified)
    Nov 22, 2021

    Colorectal Tumors, Urologic Tumors, Gastrointestinal Tumors Trial (Transvaginal natural orifice specimen extraction (NOSE))

    Completed
    • Colorectal Neoplasms
    • +3 more
    • Transvaginal natural orifice specimen extraction (NOSE)
    • (no location specified)
    Nov 5, 2021

    Urologic Tumors Trial in Guangzhou (endoscopic surgical instrument control system (SP1000: single-port laparoscopy), endoscopic

    Not yet recruiting
    • Urologic Neoplasms
    • endoscopic surgical instrument control system (SP1000: single-port laparoscopy)
    • endoscopic surgical instrument control system (IS3000: multi-port laparoscopy)
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Aug 29, 2021

    LPN in Patients With High-complex Renal Tumors

    Completed
    • Renal Cancer
    • +9 more
    • laparoscopic partial nephrectomy
    • Laparoscopic radical nephrectomy
    • Samsun, Turkey
      Ondokuz Mayıs University, Department of Urology
    Jun 13, 2021

    Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)

    Recruiting
    • Urinary Bladder Neoplasms
    • +5 more
    • tislelizumab and BCG
    • Shanghai, Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Jun 10, 2021

    Lung Cancer Metastatic, Locally Advanced Malignant Tumor, Non Hodgkin Lymphoma Trial in Marseille (Blood sample collection,

    Active, not recruiting
    • Lung Cancer Metastatic
    • +3 more
    • Blood sample collection
    • Biopsy collection
    • Marseille, Bouches-du-Rhône, France
      Institut Paoli-Calmettes
    Mar 26, 2021

    Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st

    Completed
    • Urologic Neoplasms
      • Kyoto-shi, Japan
        Research Site
      Feb 25, 2021

      Genetic Testing in Upper Tract Urothelial Carcinoma: Epicheck

      Recruiting
      • Urologic Cancer
      • Urologic Neoplasms
      • Urine biomarker
      • Barcelona, Spain
        Fundacio Puigvert
      Jan 7, 2021

      Antegrade Double-J Stent Placement for Treatment of Malignant

      Completed
      • Urologic Neoplasms
      • Antegrade double-J stent
      • (no location specified)
      Dec 2, 2020

      Metastatic Renal Cell Carcinoma, Kidney Tumor, Urologic Tumors Trial in Herlev (Medication (A specification is listed under each

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • +3 more
      • Medication (A specification is listed under each arm)
      • Patient reported outcomes measurement
      • Herlev, Denmark
        Department of Oncology, Herlev and Gentofte Hospital
      Nov 19, 2020

      Urologic Tumors Trial in France, Italy, Spain (Afatinib)

      Completed
      • Urologic Neoplasms
      • Bordeaux, France
      • +29 more
      Oct 28, 2020